Sort
39,280 grants matching “leukemia”
Immunology and Pathology of Chronic Murine Leukemia Virus Infections
$632,137Kim Hasenkrug · National Institute Of Allergy And Infectious Diseases · ZIA · FY2009 · AI
Immunology And Pathology Of Acute Murine Leukemia Virus Infections
$632,137Kim Hasenkrug · National Institute Of Allergy And Infectious Diseases · ZIA · FY2009 · AI
DNA Replication initiation Sites in Mammalian Cells
$632,122Carl L Schildkraut · Albert Einstein College Of Medicine · R01 · FY2007 · GM
Synergestic roles of SRF2 and RUNX1 in blood cell development and pathology
$632,046Dong-Er Zhang · University Of California, San Diego · R01 · FY2021 · DK
Immune Compromises Zebrafish for Cell Transplantation
$632,028David Michael Langenau · Massachusetts General Hospital · R24 · FY2013 · OD
Metabolic Reprogramming in Brain Tumors
$631,880Sabrina Miriam Ronen · University Of California, San Francisco · R01 · FY2015 · CA
The study of neuro-vascular interactions in the central nervous system
$631,806Yosuke Mukouyama · National Heart, Lung, And Blood Institute · ZIA · FY2022 · HL
Nuclear Medicine Core
$631,694Joseph G Rajendran · Fred Hutchinson Cancer Research Center · P01 · FY2011 · CA
Regulation of the metastasis promoting chemokine receptor ACKR3 by GPCR kinases, Gβγ and arrestins
$631,682John J G Tesmer · Purdue University · R01 · FY2023 · CA
Development of a Phenotype-based Predictive Analytic for Acute Myeloid Leukemia
$631,578Michael R Savona · Vanderbilt University Medical Center · R01 · FY2022 · CA
Viral Noncoding RNAs and Cell Transformation
$631,557Joan A. Steitz · Yale University · R01 · FY2024 · CA
Viral Noncoding RNAs and Cell Transformation
$631,557Joan A. Steitz · Yale University · R01 · FY2025 · CA
Credentialing murine models for glioblastoma preclinical drug development
$631,422Christopher Ryan Miller · Univ Of North Carolina Chapel Hill · R01 · FY2017 · CA
Cytokines and T Cell Development
$631,357Scott Durum · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
Targeting CDK6 expression/activity in Ph+ and Ph1-like acute lymphoblastic leukemia (ALL)
$631,337Bruno Calabretta · Thomas Jefferson University · R01 · FY2025 · CA
Development of Inhibitors of the Leukemia Fusion Protein CBFbeta-SMMHC
$630,914John Hackett Bushweller · University Of Virginia · R01 · FY2012 · CA
Pre Pilot Project
$630,893Reynold Enriquez · University Of Puerto Rico Med Sciences · U54 · FY2012 · CA
Clinical Program
$630,885William George Wierda · University Of California, San Diego · P01 · FY2014 · CA
Inflammation, Macrophage Differentiation, and Cancer
$630,814Zheng-Gang Liu · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Kansas City Clinical Oncology Program CCOP
$630,725Rakesh Gaur · Nci Community Oncology Research Program · U10 · FY2008 · CA
Training Program in Molecular Hematology
$630,706Nancy Berliner · Brigham And Women'S Hospital · T32 · FY2021 · HL
Optimizing Dual-Targeted and Dual-Armored CAR T Cells for Small Cell LungCancer
$630,691Renier Joseph Brentjens · Roswell Park Cancer Institute Corp · U01 · FY2023 · CA
Genetic Epidemiology of Chronic Lymphocytic Leukemia
$630,646Susan L Slager · Mayo Clinic Rochester · U01 · FY2009 · CA
Exercise as an Immune Adjuvant for Gamma Delta T-cell Therapies in Hematologic Malignancies
$630,619Richard J Simpson · University Of Arizona · R01 · FY2023 · CA
Genomic Architecture of LGL Leukemia
$630,575Thomas P Loughran · University Of Virginia · R01 · FY2016 · CA